Maria Palasis, President & CEO: Lyra Therapeutics LYRA Sell · Filed 25/07/14

Trade details

Type: Insider sale
Amount: $13,944.15
Shares · price: 1,565 sh · $8.91 a share
Held after: 1,098,435 sh
Stock: Lyra Therapeutics LYRA
Person: Maria PalasisPresident & CEO
Trade date: 25/07/10
Filed: 25/07/14
Days to filing: 4 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Lyra Therapeutics trades, last 26 weeks

What else happened in Lyra Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/10~25/08/09

Maria Palasis's recent trades

Maria PalasisPresident & CEO
Sell10b5-1 planLyra Therapeutics
Sell10b5-1 plan
Lyra Therapeutics
LYRA
$5,719
1,702 sh
$5,719
Filed 01/08
Traded 01/06
Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$26.6K
906 sh
$26.6K
Filed 25/12/02
Traded 25/12/01
Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$15K
500 sh
$15K
Filed 25/12/02
Traded 25/12/01
Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$34.6K
1,287 sh
$34.6K
Filed 25/11/05
Traded 25/10/31
Maria PalasisDirector
Sell10b5-1 planBeta Bionics
Sell10b5-1 plan
Beta Bionics
BBNX
$3,267
119 sh
$3,267
Filed 25/11/05
Traded 25/10/31